Latest News & Updates

Breaking News

  • 4 minutes ago

  • Pharma Now Editorial Team

Alembic Clears FDA on Fingolimod, Pressing Into MS Generics
Breaking News
Sun Pharma-Organon Deal Reshapes Biosimilars and Women's Health Scale

Pharma Now Editorial Team

Other trending news you may like to read

Alembic Clears FDA on Fingolimod, Pressing Into MS Generics

Alembic wins FDA final approval for Fingolimod 0.5 mg capsules, a generic equivalent to Novartis's Gilenya, advancing Indian generics in MS therapy.

Pharma Now Editorial Team

Pharma Now

Sun Pharma-Organon Deal Reshapes Biosimilars and Women's Health Scale

Sun Pharma's $11.75B all-cash Organon deal expands biosimilars and women's health scale, raising GMP harmonization demands across a combined global network.

Pharma Now Editorial Team

Pharma Now

100M Catch-Up Doses Across 36 Nations Stress-Test Cold Chain Limits

BCU delivers 100M+ doses to 18.3M children across 36 countries, signaling sustained cold chain and fill-finish demand for vaccine manufacturers.

Pharma Now Editorial Team

Pharma Now

Algeria Validates Trachoma Elimination, Raising the Bar for NTD Programs

Algeria becomes the 29th country to eliminate trachoma as a public health problem, validated by WHO after decades of SAFE strategy implementation.

Pharma Now Editorial Team

Pharma Now